KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Shares Outstanding (Weighted Average): 2017-2025

Historic Shares Outstanding (Weighted Average) for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $124.7 million.

  • Guardant Health's Shares Outstanding (Weighted Average) rose 1.37% to $124.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.7 million, marking a year-over-year increase of 1.37%. This contributed to the annual value of $123.6 million for FY2024, which is 4.71% up from last year.
  • Per Guardant Health's latest filing, its Shares Outstanding (Weighted Average) stood at $124.7 million for Q3 2025, which was up 0.66% from $123.9 million recorded in Q2 2025.
  • Guardant Health's 5-year Shares Outstanding (Weighted Average) high stood at $124.7 million for Q3 2025, and its period low was $100.4 million during Q1 2021.
  • Over the past 3 years, Guardant Health's median Shares Outstanding (Weighted Average) value was $123.0 million (recorded in 2024), while the average stood at $120.0 million.
  • Data for Guardant Health's Shares Outstanding (Weighted Average) shows a peak YoY rose of 19.19% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Guardant Health's Shares Outstanding (Weighted Average) stood at $101.7 million in 2021, then rose by 0.77% to $102.4 million in 2022, then climbed by 15.19% to $118.0 million in 2023, then grew by 4.71% to $123.6 million in 2024, then rose by 1.37% to $124.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $124.7 million for Q3 2025, versus $123.9 million for Q2 2025 and $123.4 million for Q1 2025.